Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation provides an update on Merus's MCLA-129, highlighting its potential impact on cancer treatment and clinical trial progress.
presentation
investor_presentation
71 Pages
Brenntag SE
TRESU Investment Holding A/S Investor Presentation 2023
investor_presentationinvestor_presentation
73 Pages
TRESU Investment Holding A/S